We are Sorry, This Page doesn't Exist

The company was formed to bring a treatment for patients with advanced Parkinson's disease to the United States......»»

A South Jersey biopharmaceutical firm spun out of the University of Pennsylvania got a boost Thursday when the Food and Drug Administration granted orphan drug designation for the company's lead new drug candidate. Linnaeus Therapeutics of Haddonfield.....»»

Aclaris Therapeutics has priced a planned $96 million stock sale, a day after shares of the firm soared to a nearly two-and-a-half-year high. The Wayne biopharmaceutical company's stock shot up more than 220% after it announced positive mid-stag.....»»

The North Carolina biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer......»»

The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments......»»

Philadelphia biopharmaceutical firm Oncoceutics Inc. said Wednesday its CEO and co-founder Wolfgang Oster has left the company as part of a leadership change. His departure, which also included stepping down from the company's board of directors, was.....»»

King of Prussia-based CSL Behring is teaming up with a group of other plasma-focused biopharmaceutical companies to develop a plasma-derived therapy that could potentially be used to treat COVID-19 patients. Other members of the alliance formed by .....»»

Context Therapeutics, a Philadelphia biopharmaceutical company focused on hormone-driven cancers, is teaming up with a Chinese biotech firm to advance the development of Context's lead new drug candidate. That experimental therapy, called onapristo.....»»

Maryland biopharmaceutical company Cerecor has completed its acquisition of Wayne-based Aevi Genomic Medicine, Inc. in a transaction involving two companies both focused on developing new therapies for rare pediatric diseases. The all-stock deal, fi.....»»

The change comes for Louisville's seventh largest independent insurance agency......»»

Annovis Bio went public Wednesday, raising $12 million through its initial public stock offering. The Berwyn biopharmaceutical company, which is developing treatments for neurological disorders including Parkinson's and Alzheimer's diseases, sold two mi.....»»

Samsung Electronics Co Ltd on Monday named its youngest president as its new smartphone chief as the firm seeks to defend its lead in the handset market from rising challenges from rivals such as Huawei Technologies Co Ltd......»»

Bala Cynwyd-based Chondrial Therapeutics has entered into a definitive merger agreement with Boston biopharmaceutical company Zafgen. The deal, expected to be completed during the first half of 2020, will result in the formation of a new publicly tr.....»»

A New York City-based private equity group with Fort Worth ties raises more than $500 million, a biopharmaceutical company raises another round of funding for a trial and more in this week's Form-D Friday......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

An attorney at Birmingham’s largest law firm has been appointed senior vice president and general counsel for the second-largest public company in Alabama. Birmingham-based Vulcan Materials Co. (NYSE: VMC) has named Denson "D." Franklin III, a par.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Onconova Therapeutics Inc. has entered into a deal to raise $3.4 million through a private stock sale, days after scrapping plans to raise a similar amount through a public stock offering. The Bucks County biopharmaceutical company, which is focu.....»»

The online retail giant has announced that Jonathan Johnson – who's led the firm since the departure of Patrick Byrne – is now its permanent CEO......»»

The online retail giant has announced that Jonathan Johnson – who's led the firm since the departure of Patrick Byrne – is now its permanent CEO......»»